MedTrace Logo

Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles

NCT04855383 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-01-05

No results posted yet for this study

Summary

This study is a randomized controlled clinical trial to compare the pregnancy outcomes of infertile women with frozen embryo transfer. The study population in frozen embryo transfer cycles receive three doses of human chorionic gonadotropin (HCG) to recognize the effectiveness of HCG on pregnancy outcomes in Reproductive Biomedicine Research Center, Royan institute, Tehran Iran.

Conditions

  • Embryo Implantation

Interventions

DRUG

The effect of intramuscular injection of triple doses of human chorionic gonadotropin in frozen embryo transfer cycles

Patients receive 5,000 IU of human chorionic gonadotropin by intramuscular injection, 72 hours before embryo transfer, on the day of embryo transfer, and 72 hours after embryo transfer.

Sponsors & Collaborators

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Mehri Mashayekhi, M.D. · Department of Endocrinology and Female Infertility, ACECR, Tehran, Iran.

  • Azar Yahyaei, M.Sc. · Department of Endocrinology and Female Infertility, ACECR, Tehran, Iran.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2022-08-22
Completion
2023-06-20

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04855383 on ClinicalTrials.gov